In situ co-amorphisation of arginine with indomethacin or furosemide during immersion in an acidic medium – A proof of concept study
- 17 October 2018
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 133, 151-160
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Influence of PVP molecular weight on the microwave assisted in situ amorphization of indomethacinEuropean Journal of Pharmaceutics and Biopharmaceutics, 2018
- Recent advances in co-amorphous drug formulationsAdvanced Drug Delivery Reviews, 2016
- Glass solution formation in water - In situ amorphization of naproxen and ibuprofen with Eudragit® E POJournal of Drug Delivery Science and Technology, 2016
- Investigation of physical properties and stability of indomethacin–cimetidine and naproxen–cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball millingJournal of Pharmacy and Pharmacology, 2015
- In situ amorphisation of indomethacin with Eudragit® E during dissolutionEuropean Journal of Pharmaceutics and Biopharmaceutics, 2013
- Drug–Drug Coamorphous Systems: Characterization and Physicochemical Properties of Coamorphous Atorvastatin with Carvedilol and GlibenclamideJournal of Pharmaceutical Innovation, 2013
- Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applicationsInternational Journal of Pharmaceutics, 2011
- Coamorphous Drug Systems: Enhanced Physical Stability and Dissolution Rate of Indomethacin and NaproxenMolecular Pharmaceutics, 2011
- Drug delivery strategies for poorly water-soluble drugsExpert Opinion on Drug Delivery, 2007
- Solid dispersion of poorly water‐soluble drugs: Early promises, subsequent problems, and recent breakthroughsJournal of Pharmaceutical Sciences, 1999